CA2321215A1 - Virus hybride adenovirus-aav et ses procedes d'utilisation - Google Patents

Virus hybride adenovirus-aav et ses procedes d'utilisation Download PDF

Info

Publication number
CA2321215A1
CA2321215A1 CA002321215A CA2321215A CA2321215A1 CA 2321215 A1 CA2321215 A1 CA 2321215A1 CA 002321215 A CA002321215 A CA 002321215A CA 2321215 A CA2321215 A CA 2321215A CA 2321215 A1 CA2321215 A1 CA 2321215A1
Authority
CA
Canada
Prior art keywords
hybrid
aav
transgene
host cell
aav virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002321215A
Other languages
English (en)
Other versions
CA2321215C (fr
Inventor
James M. Wilson
William M. Kelley
Krishna J. Fisher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
The Trustees Of The University Of Pennsylvania
James M. Wilson
William M. Kelley
Krishna J. Fisher
Trustees Of The University Of Pennsylvania (The)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/331,384 external-priority patent/US5856152A/en
Application filed by The Trustees Of The University Of Pennsylvania, James M. Wilson, William M. Kelley, Krishna J. Fisher, Trustees Of The University Of Pennsylvania (The) filed Critical The Trustees Of The University Of Pennsylvania
Priority claimed from CA 2203808 external-priority patent/CA2203808C/fr
Publication of CA2321215A1 publication Critical patent/CA2321215A1/fr
Application granted granted Critical
Publication of CA2321215C publication Critical patent/CA2321215C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002321215A 1994-10-28 1995-10-27 Virus hybride adenovirus-aav et ses procedes d'utilisation Expired - Lifetime CA2321215C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/331,384 1994-10-28
US08/331,384 US5856152A (en) 1994-10-28 1994-10-28 Hybrid adenovirus-AAV vector and methods of use therefor
CA 2203808 CA2203808C (fr) 1994-10-28 1995-10-27 Virus hybride adenovirus-aav et ses procedes d'utilisation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA 2203808 Division CA2203808C (fr) 1994-10-28 1995-10-27 Virus hybride adenovirus-aav et ses procedes d'utilisation

Publications (2)

Publication Number Publication Date
CA2321215A1 true CA2321215A1 (fr) 1996-05-09
CA2321215C CA2321215C (fr) 2009-04-14

Family

ID=25679278

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002321215A Expired - Lifetime CA2321215C (fr) 1994-10-28 1995-10-27 Virus hybride adenovirus-aav et ses procedes d'utilisation

Country Status (1)

Country Link
CA (1) CA2321215C (fr)

Also Published As

Publication number Publication date
CA2321215C (fr) 2009-04-14

Similar Documents

Publication Publication Date Title
WO1996013598A3 (fr) Virus hybride adenovirus-aav et ses procedes d'utilisation
WO2000028061A3 (fr) Sequences d'acide nucleique du serotype i du virus associe aux adenovirus, vecteurs et cellules hotes contenant ces derniers
WO1999011764A3 (fr) Procedes de generation de preparations de vecteurs de aav recombinants dont le titre est eleve et qui sont exemptes de virus assistant
CA2192215A1 (fr) Genome du virus adeno-associe recombine codant une proteine du virus de l'immunodeficience
EP0793713A4 (fr) Systemes de vecteurs derives de virus adeno-associes destines a l'apport et a l'integration d'un gene dans des cellules cible
CA2236968A1 (fr) Fonctions accessoires servant a produire des virions de vaa recombines
CA2161962A1 (fr) Vecteurs d'adenovirus pour therapie genique
WO2003052052A3 (fr) Sequences du serotype 9 du virus associe a l'adenovirus (aav), vecteurs les contenant et utilisations correspondantes
WO2003052051A3 (fr) Sequences du serotype 8 du virus associe a l'adenovirus (aav), vecteurs les contenant et utilisations correspondantes
WO2003092594A3 (fr) Vecteurs viraux et procedes de production et d'utilisation de ceux-ci
CA2303477A1 (fr) Adenovirus chimeres
CA2187626A1 (fr) Transmission par virus adenoassocie d'adn a des cellules du systeme nerveux
CA2418442A1 (fr) Nouvelles fonctions auxiliaires destinees a la production de vecteurs recombinants
EP1707631A3 (fr) Procédé amélioré pour production et purification de vecteurs d'adénovirus
CA2366861A1 (fr) Compositions et techniques de production sans auxiliaire de virus adeno-associes de recombinaison
JP2002538770A5 (fr)
WO1998011244A3 (fr) Vecteur de vaa4 et ses utilisations
AU681705B2 (en) Endosomolytically active particles
WO2000003030A3 (fr) Poxvirus recombine du raton laveur et ses utilisations comme vaccin chez des especes mammiferes et aviaires
AU6704496A (en) Helper viruses for the preparation of recombinant viral vectors
CA2421442A1 (fr) Cellules hotes pour empaqueter un virus adeno-associe recombine (raav), leur procede de preparation et leur utilisation
CA2047290A1 (fr) Virus recombinant de la maladie de marek
NZ334827A (en) High-capacity adenoviral vectors suitable for adenoviral-based gene therapy
WO1998055639A3 (fr) Vecteurs adenoviraux recombinants comprenant une sequence d'epissage
WO2001025253A3 (fr) Regulation sensible thermiquement de production de vecteurs viraux

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20151027